The authors have no conflicts of interest to declare.
Preliminary investigation of adjustable balloon implant for type I thyroplasty†
Article first published online: 8 FEB 2011
Copyright © 2011 The American Laryngological, Rhinological, and Otological Society, Inc., Rhinological, and Otological Society, Inc.
Volume 121, Issue 4, pages 793–800, April 2011
How to Cite
Hoffman, M. R., Witt, R. E., McCulloch, T. M. and Jiang, J. J. (2011), Preliminary investigation of adjustable balloon implant for type I thyroplasty. The Laryngoscope, 121: 793–800. doi: 10.1002/lary.21431
- Issue published online: 23 MAR 2011
- Article first published online: 8 FEB 2011
- Manuscript Accepted: 3 NOV 2010
- Manuscript Received: 30 JUL 2010
- Adjustable balloon implant;
- medialization thyroplasty;
- vocal fold paralysis
We present the adjustable balloon implant (ABI), a novel implant to be used in type I thyroplasty for the treatment of vocal fold paralysis. The ABI offers the same medialization provided by other implants, but can easily be catered to individual patient anatomy as well as modified postoperatively without the need for a revision thyroplasty.
Repeated measures with each larynx serving as its own control.
Medialization thyroplasty (MT) with the ABI was performed on five excised canine larynges. Mucosal wave, aerodynamic, and acoustic parameters were measured for three conditions: normal; right vocal fold paralysis; and paralysis with the ABI.
Insertion of the ABI resulted in significant decreases in both phonation threshold pressure and phonation threshold flow. Perturbation parameters of percent jitter and percent shimmer were also significantly decreased and restored to normal levels. Signal-to-noise ratio was significantly increased to the normal level as well. The mucosal wave was preserved after implant insertion.
This preliminary experiment showing significant improvements in aerodynamic and acoustic parameters demonstrates the potential of the ABI as a thyroplasty implant. Effective medialization and preservation of the mucosal wave combined with postoperative adjustability makes it a potentially valuable clinical device. Laryngoscope, 2011